The Cigna Group CGN
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
News
-
Cigna Group Lifts Outlook, Logs Higher 2Q Profit on Growth Across Businesses
-
Cigna 1Q Revenue Rises on Evernorth Growth
-
U.S. Health Insurers Step Up Prior Authorization Reforms Amid Industry Pressure — Update
-
Cigna Names Brian Evanko CEO as David Cordani Retires — Update
-
Cigna's longtime CEO to step down as health insurers face growing scrutiny
-
Cigna Names Brian Evanko CEO as David Cordani Retires
-
FTC Settles Litigation With Express Scripts Over Insulin Drug Pricing
-
More Americans are choosing Obamacare plans they can't afford in first look at ACA without enhanced tax credits
Trading Information
- Previous Close Price
- €247.10
- Day Range
- €250.20–252.20
- 52-Week Range
- €210.05–268.40
- Bid/Ask
- €0.00 / €0.00
- Shares Outstanding
- 264.24M
- Market Cap
- $66.64B
- Volume/Avg
- 12 / 20
Key Statistics
- Price/Earnings (Normalized)
- 9.35
- Price/Sales
- 0.28
- Dividend Yield (Trailing)
- 2.13%
- Dividend Yield (Forward)
- 2.16%
- Dividend Payment Schedule
- Mar, Jun, Sep, Dec
- Total Yield
- 3.49%
Company Profile
Cigna primarily provides pharmacy benefit management and health insurance services. Its PBM and specialty pharmacy services, which were greatly expanded by its 2018 merger with Express Scripts, are mostly sold to health insurance plans and employers. Its largest PBM contract is with the Department of Defense, and it recently won a multiyear deal with top-tier insurer Centene. In health insurance and other benefits, Cigna primarily serves employers through self-funding arrangements, and the company operates mostly in the US with 16 million US and 2 million international medical members covered as of December 2025.
- Sector
- Healthcare
- Industry
- Healthcare Plans
- Stock Style Box
- Mid Value
- Total Number of Employees
- 67,700
- Website
- https://www.thecignagroup.com
Valuation
|
Metric
|
CGN
|
|---|---|
Price/Earnings (Normalized) | 9.35 |
Price/Book Value | 1.78 |
Price/Sales | 0.28 |
Price/Cash Flow | 7.75 |
Price/Earnings
CGN
Financial Strength
|
Metric
|
CGN
|
|---|---|
Quick Ratio | 0.68 |
Current Ratio | 0.85 |
Interest Coverage | 7.08 |
Quick Ratio
CGN
Profitability
|
Metric
|
CGN
|
|---|---|
Return on Assets (Normalized) | 5.37% |
Return on Equity (Normalized) | 20.03% |
Return on Invested Capital (Normalized) | 12.89% |
Return on Assets
CGN
Healthcare Plans Industry Comparables
|
1-Day Chart
|
Name
|
Price
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|---|
| UnitedHealth Group Inc
UNH
| LOCK|&&l?P&k | LOCK|%nK## | $340B | |||
| CVS Health Corp
CVS
| LOCK|%stTG<! | LOCK|lv | $110B | |||
| Elevance Health Inc
ELV
| LOCK|wg!LG& | LOCK|GknT? | $90B | |||
| The Cigna Group
CI
| LOCK|BJ&y!MX | LOCK|l#^Yq | $75B | |||
| Humana Inc
HUM
| LOCK|vZ>&%g | LOCK|^wfG | $52B | |||
| Centene Corp
CNC
| LOCK|dc^@?# | LOCK|^!V | $32B | |||
| Oscar Health Inc Class A
OSCR
| — | LOCK|<s! | $10B | |||
| Molina Healthcare Inc
MOH
| LOCK|s%<^PCY | LOCK|!$b&b | $10B | |||
| Clover Health Investments Corp Ordinary Shares - Class A
CLOV
| — | LOCK|Qy! | $3B | |||
| Progyny Inc
PGNY
| — | LOCK|h^D | $2B |
United States